ISPOR 2023: preview of the plenary sessions
With the ISPOR 2023 conference (May 7–10, 2023, Boston, USA) only a few weeks away, the Society has announced details of the much-anticipated plenary sessions. Here we provide details of the three key plenaries and what to expect.
View the full program here >>>
Plenary 1
Global Focus on Affordability and Inward Investment – What Does it Mean for HEOR?
Date and time: Monday 8th May, 8:30am – 9:45am
Moderator: Samantha Roberts, Chief Executive, National Institute of Health and Care Excellence (NICE), UK and Conference Co-Chair
Speakers: John M O’Brien, National Pharmaceutical Council, Washington, DC, USA
Overview: Governments worldwide are increasingly implementing measures, such as price negotiations and rebate reductions, to manage the affordability of medicines and encourage inward investment by life science companies. This session will explore the role of health economics and outcomes research (HEOR) in the affordability and investment debate, looking at the global implications of new policies and their impact on the current and future pricing and access of medicines.
Plenary 2
AI Wants to Chat With You: Accept or Ignore?
Date and time: Tuesday 9th May, 8:30am – 9:45am
Moderators: Blythe Adamson, Flatiron Health, New York, NY, USA and Mitchell Higashi, Sema4, Princeton, NJ, USA
Speakers: Guillermo Cecchi, IBM Research, New York, NY, USA; David Sontag, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA; and Sunny Virmani, Google, San Francisco, CA, USA
Overview: The past few years have seen a seismic shift in the interest and potential application of artificial intelligence (AI). This session will delve into the potential impact of AI on HEOR, with the speakers providing their perspectives on the anticipated changes as AI continues to gain traction in healthcare.
Plenary 3
Issues and Solutions When Estimating Treatment Effects Using US Electronic Health Record Data
Date and time: Wednesday 10th May, 11:30am – 12:45pm
Moderators: Sebastian Schneeweiss, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
Speakers: Rebecca Hubbard, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Jeremy Rassen, Aetion, Inc., New York, NY, USA; Janick Weberpals, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA; and Richie Wyss, Harvard Medical School, Brigham and Women’s Hospital and Sentinel Innovation Center, Boston, MA, USA
Overview: Real-world data captured through electronic health records (EHR) is being more broadly utilized in many avenues of real-world evidence generation, including claims-based studies in estimating causal treatment effects. However, several issues need to be addressed for EHR data to fully support critical healthcare decisions. The session aims to provide insights into addressing these challenges in utilizing EHR data for healthcare research.
You may also be interested in:
Exclusive coverage by The Evidence Base
The Evidence Base team will be attending ISPOR 2023 to provide coverage of the event, including ‘Look Behind the Lecture’ interviews with some of the experts speaking at the event. All content, including our conference round-up, will be featured on our ISPOR event page and shared via social media channels.
If you’re attending the conference and are interested in meeting with the team at the event to be interviewed for The Evidence Base or contributing to the Journal of Comparative Effectiveness Research, please email Joanne Walker, Co-Founder & Publishing Director, Becaris Publishing Limited.
Partner with us
ISPOR 2023 coverage on The Evidence Base will generate significant engagement.
If you wish to showcase your company or products on our dedicated page pre-, during- and post-event, to reach The Evidence Base audience, then please get in touch to discuss options.
Message Phil Garner, Co-Founder & CEO, Becaris Publishing Limited, for more information on how to partner with us for this important event.
